HUBEI KAILONG CHEMICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.27 CNY | -1.90% |
|
+3.89% | -28.65% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,147 | 4,354 | 3,796 | 4,115 | 3,315 | 4,534 |
| Enterprise Value (EV) 1 | 2,227 | 4,812 | 5,197 | 5,809 | 4,865 | 6,163 |
| P/E ratio | 26.8 x | 84 x | 77.3 x | -10.1 x | 24.3 x | 25.8 x |
| Yield | 3.11% | 0.85% | 1% | - | 1.18% | 0.86% |
| Capitalization / Revenue | 1.15 x | 2.3 x | 1.89 x | 1.5 x | 0.97 x | 1.2 x |
| EV / Revenue | 1.19 x | 2.54 x | 2.58 x | 2.12 x | 1.43 x | 1.63 x |
| EV / EBITDA | 6.35 x | 11.9 x | 12.6 x | 14.1 x | 8.19 x | 7.82 x |
| EV / FCF | 86 x | -18.7 x | 11.7 x | 34.7 x | 25.8 x | -272 x |
| FCF Yield | 1.16% | -5.34% | 8.54% | 2.88% | 3.87% | -0.37% |
| Price to Book | 1.42 x | 2.58 x | 2.21 x | 3.19 x | 2.24 x | 2.89 x |
| Nbr of stocks (in thousands) | 333,880 | 370,265 | 377,722 | 381,730 | 390,414 | 391,239 |
| Reference price 2 | 6.430 | 11.76 | 10.05 | 10.78 | 8.490 | 11.59 |
| Announcement Date | 4/19/19 | 5/21/20 | 4/27/21 | 4/26/22 | 4/15/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,865 | 1,891 | 2,011 | 2,741 | 3,406 | 3,779 |
| EBITDA 1 | 350.8 | 403 | 414.1 | 413 | 594.2 | 788.4 |
| EBIT 1 | 234.4 | 238.2 | 216.4 | 116 | 307.5 | 452 |
| Operating Margin | 12.57% | 12.59% | 10.76% | 4.23% | 9.03% | 11.96% |
| Earnings before Tax (EBT) 1 | 167.4 | 153 | 118.7 | -500.5 | 188.9 | 302.8 |
| Net income 1 | 81.76 | 49.98 | 50.34 | -407.1 | 133.4 | 175.4 |
| Net margin | 4.38% | 2.64% | 2.5% | -14.85% | 3.92% | 4.64% |
| EPS 2 | 0.2400 | 0.1400 | 0.1300 | -1.070 | 0.3500 | 0.4500 |
| Free Cash Flow 1 | 25.88 | -256.8 | 443.9 | 167.4 | 188.4 | -22.66 |
| FCF margin | 1.39% | -13.58% | 22.07% | 6.11% | 5.53% | -0.6% |
| FCF Conversion (EBITDA) | 7.38% | - | 107.2% | 40.53% | 31.71% | - |
| FCF Conversion (Net income) | 31.66% | - | 881.71% | - | 141.27% | - |
| Dividend per Share 2 | 0.2000 | 0.1000 | 0.1000 | - | 0.1000 | 0.1000 |
| Announcement Date | 4/19/19 | 5/21/20 | 4/27/21 | 4/26/22 | 4/15/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 80.4 | 458 | 1,401 | 1,694 | 1,551 | 1,629 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.2292 x | 1.137 x | 3.383 x | 4.102 x | 2.61 x | 2.066 x |
| Free Cash Flow 1 | 25.9 | -257 | 444 | 167 | 188 | -22.7 |
| ROE (net income / shareholders' equity) | 7.34% | 5.43% | 3.85% | -20.6% | 7.16% | 10.4% |
| ROA (Net income/ Total Assets) | 4.72% | 3.62% | 2.43% | 1.07% | 2.69% | 3.78% |
| Assets 1 | 1,731 | 1,380 | 2,068 | -37,927 | 4,958 | 4,633 |
| Book Value Per Share 2 | 4.520 | 4.560 | 4.550 | 3.370 | 3.780 | 4.020 |
| Cash Flow per Share 2 | 3.390 | 1.460 | 2.200 | 1.410 | 2.620 | 1.340 |
| Capex 1 | 327 | 609 | 285 | 259 | 235 | 484 |
| Capex / Sales | 17.53% | 32.22% | 14.18% | 9.44% | 6.89% | 12.82% |
| Announcement Date | 4/19/19 | 5/21/20 | 4/27/21 | 4/26/22 | 4/15/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -28.65% | 572M | |
| +14.24% | 5.87B | |
| +25.00% | 2.22B | |
| +16.19% | 1.85B | |
| +11.87% | 1.8B | |
| +13.37% | 1.01B | |
| +18.81% | 760M | |
| -16.42% | 699M | |
| +3.75% | 490M | |
| -14.88% | 358M |
- Stock Market
- Equities
- 002783 Stock
- Financials Hubei Kailong Chemical Group Co., Ltd.